The deadline to submit an abstract submission has passed.

The CAHR 2016 Scientific Program Committee invites abstracts in the areas of: Basic Science, Clinical Science, Epidemiology and Public Health, and Social Sciences. Click on the link below to go directly to any of the following sections:

 

Abstract Submission Guidelines and Policies

Submission of an abstract acknowledges your consent to the following.

  • If accepted, your abstract may be published in a medical publication.
  • If accepted as an oral presentation, your PPT presentation will be posted on the CAHR website post conference.
  • If accepted as a poster presentation, you will display your poster at the Conference.
  • You agree to prepare a “one-page media profile sheet” on your abstract for distribution to media if requested by CAHR 2016.
  • You agree to allow Rapporteurs to use all or part of your presentation or poster in the Rapporteur presentation at CAHR 2016. The Rapporteur presentation will not be made available for public presentation or downloading.

 

Abstract Submission and Review Timeline

The deadline for abstract submission is Wednesday, January 13, 2016. The results of the peer review will be announced in the week of February 29, 2016. The submitting author will be notified by email. Subsequent correspondence will be with the presenting author(s).

Presenting Author Registration

Presenting Authors must register to attend CAHR 2016. If you are not registered by the Presenting Author registration deadline of Thursday, March 17, 2016 your abstract may not be included in the final program.

Author Information

At the beginning of the abstract submission process, you will be asked to enter author information and affiliations.

Policy – Abstract Submitter – This policy is intended to support the broadest number of researchers to participate in the Conference program. Any researcher, who is submitting an abstract or presenting an oral session or an abstract poster, must be a member of the research or investigation team.

Disclosure of potential Conflict of Interest – If, within the past five years, an author or immediate family member has had a substantial personal financial relationship relating to the support of the abstract, this relationship must be described. Such relationships include salaries, ownerships, equity positions, stock options, royalties, consulting fees and honoraria for speaking, material support and other financial arrangements. During the abstract submission process you will be asked to disclose any potential conflicts of interest. Find out more about CAHR’s Policy on Disclosure of Potential Conflicts of Interest.

Language of Abstract

Your abstract should be in English or French, and will be published in the language of submission.

Number of Submissions

There is a limit of two abstract submissions per presenting author.

Researchers are limited to presenting two abstracts per researcher during the Conference program (including oral sessions and abstract posters). If the author wishes to submit more than two (2) abstracts, they can and should be submitted by another researcher as part of the investigation team (that is, other than the principal investigator or presenting researcher). There is no limit to the number of times that a researcher’s name may appear as a member of a team of investigators on abstracts submitted to the conference. In cases where a researcher is involved in more than two abstracts or studies submitted for the Conference program, that researcher may be listed as the presenter only twice (oral session or abstract poster).

Title and Abstract Length

The abstract title is limited to 140 characters. Please use Title Case (capital letters to start the principal words) for your abstract title instead of all CAPITAL or all small letters. Abstracts should be no more than 300 words in length, not including the title. Please note that abstracts will be truncated at 300 words in the Journal if they run longer. If you incorporate a data table in your abstract, the table counts as 50 words against your 300 word total.

Please make sure you preview your abstract before submitting. We recommend you print the preview and proof the printed copy.

Submission Format

Prepare your abstract in a word processing software such as MS Word, WordPerfect, or a text editor such as MS Write. Do not use presentation software such as PowerPoint. If you incorporate a data table in your abstract, the table counts as 50 words against your 300 word total.

Preferred Presentation Format

Please select one of the following presentation options during online abstract submission:

  • Oral
  • Poster

Only a limited number of oral presentations are possible, and therefore many authors wishing an oral cannot be accommodated. Authors selecting oral as their preference will be offered a poster presentation if not selected for an oral, but the Scientific Program Committee will note their strong preference for an oral.

Canadian Connection Policy

Scientific abstracts submitted for CAHR conference program should demonstrate a clear Canadian connection.

“Canadian connection” would include, but not be limited to, the following criteria as general guidelines. To demonstrate a Canadian connection, an abstract would need to meet at least one or more of these criteria:

  • one or more investigators are based in Canada, are Canadian residents or trained in Canada
  • one or more funders are based in Canada, i.e. a Canadian funder, or other national or international funder (organization or individual) that is based in or operating in Canada
  • one or more Canadian scientific research or other organizations based in Canada is involved or partnered in the research project
  • at least some of the research population is resident in Canada
  • at least some of the research activity is conducted in Canada
  • the research builds extensively on existing Canadian research
  • the evidence from the research is relevant, wholly or partially, to current issues and challenges specific to the HIV/AIDS response in Canada
  • other connection such as the research was initiated, proposed or promoted by Canadian researcher(s) or institution(s).

Back to Top

Abstract Subjects

Basic Sciences

  • Co-Morbidities, including HCV
  • HIV Immunology
  • HIV Molecular Epidemiology, including Host Genetics and HIV Evolution
  • HIV Prevention (Preclinical), including Antiretrovirals, Microbicides, Vaccines, and HIV Resistance
  • HIV Virology/Pathogenesis, including Antiviral Mechanisms
  • Other

Clinical Sciences

  • Adherence
  • Clinical Trials and Observational Studies of Antiretrovirals and Other HIV Therapies
  • Co-infections (including HCV, HBV, HPV, Syphilis, TB)
  • Complications of Antiretroviral Therapy
  • Early Treatment, Reservoirs, and Cure
  • HIV and Aging and Comorbidities  (changed from HIV and Aging – including CVD, Osteoporosis, Neurocognitive Effects)
  • HIV in Children and Adolescents
  • HIV in Vulnerable Populations and Global Health Issues
  • HIV in Women and in Pregnancy
  • HIV Prevention
  • Mental Health Issues for HIV Positive Persons
  • Lab Testing and Monitoring
  • Opportunistic Infections and Malignancies
  • Pharmacology, Pharmacokinetics and Pharmacoeconomics
  • Resistance
  • Substance Use and HIV
  • Other

Epidemiology and Public Health Sciences

  • Data Science, Data Visualization and “Big Data” in Public Health Research
  • Demography of HIV and Estimates of Key Population Sizes
  • Economic Evaluation of Policies, Programs or Interventions
  • Epidemiology and Surveillance of HIV Co-infections
  • Epidemiology and Surveillance of HIV/AIDS
  • Evaluations of Public Health Programs and Interventions
  • HIV prevention for key populations
  • HIV Program Science
  • Interdisciplinary Epidemiology (Biological, Behavioural and Social) or Biopsychosocial Research
  • Introducing New Data Sources: Cohort Studies, Administrative Databases, Surveys, etc.
  • Methodological Advances in Epidemiology, Public Health and Mathematical Modelling
  • Policy Evaluations
  • Process Advances and Lessons Learned in Complex or Community-based Public Health Research
  • Public Health Ethics
  • Social Determinants of HIV Prevention, Risk, Testing, and Care
  • Social epidemiology of HIV infection (structural, social and individual determinants)
  • Other

Social Sciences

  • Aboriginal Health
  • Combining Prevention Strategies: Social Scientific Perspectives
  • Critical Approaches to Community-Based Research
  • Critical Social Theory: Applications and Advancements in Understanding the HIV Epidemic
  • Engaging (with) Communities in HIV Research
  • Everyday Actualities of Living with HIV
  • Gay, Bisexual and other Homosexually Active Men
  • Intervention Based Research in the Social Sciences: Theories, Methodologies, and Outcomes
  • Organizational Strategies in the Context of Policy and Funding Shifts
  • Pleasure, Intimacy and Romance in the HIV Era
  • Sex, Sexuality and Gender: Populations across Diverse Contexts and Axes of Inequity
  • Social, Structural and Systemic Drivers of HIV
  • Substance Use, Transmission Networks and Local Contexts of HIV Risk
  • The Health of African, Caribbean and Black Communities
  • The Medico-Legal Borderland: Criminalization, Law, Policy and Resistance
  • Other

Back to Top

Scholarships and Awards

Academic Scholarships as well as New Investigator Awards will be presented to selected candidates. For application details, visit the Scholarships & Awards page. Please note that you must apply for scholarships and awards when submitting your abstract.

Back to Top

Abstract Presentation Guidelines and Policies

General Policy – Abstract Presenter

This policy is intended to support the broadest number of researchers to participate in the Conference program. Any researcher, who is submitting an abstract or presenting an oral session or an abstract poster, must be a member of the research or investigation team.

Researchers are limited to presenting two abstracts per researcher during the Conference program (including oral sessions and abstract posters). If the author wishes to submit more than two (2) abstracts, they can and should be submitted by another researcher as part of the investigation team (that is, other than the principal investigator or presenting researcher). There is no limit to the number of times that a researcher’s name may appear as a member of a team of investigators on abstracts submitted to the conference. In cases where a researcher is involved in more than two abstracts or studies submitted for the Conference program, that researcher may be listed as the presenter only twice (oral session or abstract poster).

Exceptions to this policy may be considered on a case-by-case basis where in the opinion of the Track Chair and/or Conference Organizing Committee, such an exception may enhance the Conference program and/or advance HIV research and/or knowledge exchange. All decisions of the Conference Organizing Committee are final.

Oral Presentation

The oral presentations are scheduled on Friday, May 13th and Saturday, May 14. You will be notified about your presentation time once your abstract is accepted as oral presentation. Oral presentations are 10 minutes in length, and will be followed by 5 minutes for questions and answers. New Investigator Awards applicants will be reviewed during their presentation, and the awards recipients announced on the final day of the Conference.

Poster Presentation

Posters will be presented between Thursday, May 12th and Saturday, May 14th. Information on poster viewing times, poster size, set-up and removal will be included in the abstract notification email. In addition to presenting your poster at the Conference, presenters are obligated to submit their poster as PDF to CAHR for posting on the CAHR website post conference.

Back to Top

Submit your Abstract(s)

The deadline to submit an abstract submission has passed.

Back to Top

Edit your submitted Abstract(s)

You can only edit your abstract until the abstract submission deadline.

Back to Top

Questions?

Please email your questions on abstract submission to cahr@scolars.com.